Crizotinib HCl
10mM in DMSO
- Product Code: 157838
CAS:
1415560-69-8
| Molecular Weight: | 486.8 g./mol | Molecular Formula: | C₂₁H₂₂Cl₂FN₅O·HCl |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of non-small cell lung cancer (NSCLC) that is caused by abnormalities in the ALK or ROS1 genes. It works by blocking the action of abnormal proteins that signal cancer cells to grow, helping to slow or stop the spread of cancer. Often prescribed for patients with advanced or metastatic disease, it is taken orally and can lead to significant tumor shrinkage in responsive patients. Also investigated for use in other cancers involving ALK or ROS1 mutations, such as neuroblastoma and inflammatory myofibroblastic tumors.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿6,590.00 |
+
-
|
Crizotinib HCl
Used in the treatment of non-small cell lung cancer (NSCLC) that is caused by abnormalities in the ALK or ROS1 genes. It works by blocking the action of abnormal proteins that signal cancer cells to grow, helping to slow or stop the spread of cancer. Often prescribed for patients with advanced or metastatic disease, it is taken orally and can lead to significant tumor shrinkage in responsive patients. Also investigated for use in other cancers involving ALK or ROS1 mutations, such as neuroblastoma and inflammatory myofibroblastic tumors.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :